
Diisopropyl succinate | CAS:924-88-9
Diisopropyl succinate
- 名称:丁二酸二异丙酯 | Diisopropyl succinate
- CAS号:924-88-9
- 别名:Succinic acid diisopropyl ester
- 分子式:C10H18O4
- 分子量:202.25
- EINESC号:213-110-0
产品描述
物理化学性质
没有数据 | 没有数据 |
---|
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
TCI | 浏览或下载 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia.Georg Hopfinger et al.Cancer, 119(12), 2258-2267 (2013-03-21)
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.Izabela Sadowska-Bartosz et al.Journal of neuroimmunology, 266(1-2), 67-74 (2013-12-03)
Cannabidiol enhances xenobiotic permeability through the human placental barrier by direct inhibition of breast cancer resistance protein: an ex vivo study.Valeria Feinshtein et al.American journal of obstetrics and gynecology, 209(6), 573-573 (2013-08-13)
Cladribine in the treatment of acute myeloid leukemia.Tadeusz Robak et al.Leukemia research, 38(4), 425-427 (2014-02-04)
Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinotecan-drug eluting beads.Vugar Yagublu et al.Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 13(1), 79-87 (2013-02-12)
Outcome of poor response paediatric AML using early SCT.Neval E Wareham et al.European journal of haematology, 90(3), 187-194 (2012-12-12)
Synthesis and biological evaluation of new cytotoxic indazolo[4,3-gh]isoquinolinone derivatives.Manochehr Shahabi et al.Bioorganic & medicinal chemistry letters, 23(6), 1846-1852 (2013-02-12)
Estrogen receptor α induction by mitoxantrone increases Abcg2 expression in placental trophoblast cells.Kenji Oda et al.Journal of pharmaceutical sciences, 102(9), 3364-3372 (2013-04-18)
Solid lipid nanoparticles of anticancer drugs against MCF-7 cell line and a murine breast cancer model.Yu-Gang Zhuang et al.Die Pharmazie, 67(11), 925-929 (2012-12-06)
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.Markus Axelsson et al.Journal of neuroimmunology, 264(1-2), 100-105 (2013-10-16)
Mathematical modeling of drug release from nanostructured porous Si: combining carrier erosion and hindered drug diffusion for predicting release kinetics.Adi Tzur-Balter et al.Acta biomaterialia, 9(9), 8346-8353 (2013-06-19)
Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma.Robert S Nickel et al.Pediatric blood & cancer, 61(5), 810-814 (2013-12-21)
Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues.Krupa J Patel et al.Cancer chemotherapy and pharmacology, 72(1), 127-138 (2013-05-18)
Role of immunosuppressive therapy for the treatment of multiple sclerosis.James M Stankiewicz et al.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 10(1), 77-88 (2012-12-29)
A case report of acute myeloid leukemia after liver transplantation.Mingjuan Liu et al.Acta haematologica, 129(4), 225-228 (2013-01-09)
Phase II trial assessing granulocyte-macrophage-colony stimulating factor, ketoconazole plus mitoxantrone in metastatic castration-resistant prostate cancer progressing after docetaxel treatments.Robert J Amato et al.Cancer investigation, 31(3), 177-182 (2013-02-14)
Novel dual drug-loaded block ionomer complex micelles for enhancing the efficacy of chemotherapy treatments.Thiruganesh Ramasamy et al.Journal of biomedical nanotechnology, 10(7), 1304-1312 (2014-05-09)
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.Dario Ferrero et al.Annals of hematology, 93(8), 1391-1400 (2014-04-08)
Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy.Susan Halabi et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(31), 3944-3950 (2013-10-09)
Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failure.Michael V Jaglal et al.Leukemia research, 38(4), 443-446 (2014-01-21)
Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.Samir H Barghout et al.Leukemia, 33(1), 37-51 (2018-06-10)
Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride.Adi Tzur-Balter et al.Acta biomaterialia, 9(4), 6208-6217 (2013-01-01)
Antiviral activity of mitoxantrone dihydrochloride against human herpes simplex virus mediated by suppression of the viral immediate early genes.Qiang Huang et al.BMC microbiology, 19(1), 274-274 (2019-12-10)
Dermatic Scedosporium apiospermum infection after autologous bone marrow transplantation.Zhiyong Yu et al.Internal medicine (Tokyo, Japan), 52(6), 689-693 (2013-03-19)
AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.Hui Zhang et al.Cancer letters, 350(1-2), 61-68 (2014-04-22)
Mechanism-independent optimization of combinatorial nanodiamond and unmodified drug delivery using a phenotypically driven platform technology.Hann Wang et al.ACS nano, 9(3), 3332-3344 (2015-02-18)
On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs.Chyuan-Chuan Wu et al.Nucleic acids research, 41(22), 10630-10640 (2013-09-17)
A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response.FitzGerald J PLoS ONE, 9, e98891-e98891 (2014)
Calreticulin surface exposure is abrogated in cells lacking, chaperone-mediated autophagy-essential gene, LAMP2A.A D Garg et al.Cell death & disease, 4, e826-e826 (2013-10-05)
Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.Yuting Ma et al.The Journal of experimental medicine, 208(3), 491-503 (2011-03-09)
Evaluation of efficacy, safety and tolerability of fingolimod in patients with the relapsing form of multiple sclerosis - 12-month observation. A preliminary report.Zdzisław Maciejek et al.Neurologia i neurochirurgia polska, 47(2), 145-151 (2013-05-08)
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.J M Day et al.British journal of cancer, 100(3), 476-486 (2009-01-22)
High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission.Mona Hassanein et al.Leukemia research, 37(5), 556-560 (2013-01-30)
Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: in vitro and in vivo investigations.Sobiya Zafar et al.International journal of pharmaceutics, 477(1-2), 454-468 (2014-12-03)
High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement.Bushan Xie et al.Biochemical and biophysical research communications, 521(1), 232-237 (2019-10-28)
Molecular mechanism of T-cell protein tyrosine phosphatase (TCPTP) activation by mitoxantrone.Mikko Ylilauri et al.Biochimica et biophysica acta, 1834(10), 1988-1997 (2013-07-17)
Spectroscopic studies of the effects of anticancer drug mitoxantrone interaction with calf-thymus DNA.Shweta Agarwal et al.Journal of photochemistry and photobiology. B, Biology, 120, 177-182 (2012-12-26)
Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines.Jurjen M Ruben et al.Cancer immunology, immunotherapy : CII, 63(4), 335-345 (2014-01-05)
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lymphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi.Massimo Federico et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(12), 1506-1513 (2013-03-27)
Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML.Jorge E Cortes et al.Cancer, 121(2), 234-242 (2014-09-17)
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: results of a randomized phase III trial by the EORTC and GIMEMA consortium (AML-17).Sergio Amadori et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31(35), 4424-4430 (2013-10-16)
Use of surgery and mitoxantrone chemotherapy in a dog with disseminated lymphangiosarcoma.Véronique Sicotte et al.Journal of the American Veterinary Medical Association, 241(12), 1639-1644 (2012-12-12)
A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells.Michod D Oncogene, 23, 8971-8971 (2004)
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress.Juliette Humeau et al.EMBO molecular medicine, 12(5), e11622-e11622 (2020-04-24)
Non-Thermal Plasma as a Unique Delivery System of Short-Lived Reactive Oxygen and Nitrogen Species for Immunogenic Cell Death in Melanoma Cells.Abraham Lin et al.Advanced science (Weinheim, Baden-Wurttemberg, Germany), 6(6), 1802062-1802062 (2019-04-03)
Unblending of Transcriptional Condensates in Human Repeat Expansion Disease.Shaon Basu et al.Cell, 181(5), 1062-1079 (2020-05-11)
Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.Janet M Pavese et al.Cancer letters, 352(2), 179-186 (2014-07-13)
Chromium(VI) but not chromium(III) species decrease mitoxantrone affinity to DNA.Anna M Nowicka et al.The journal of physical chemistry. B, 117(4), 1021-1030 (2013-01-09)
Clinical efficacy of mitoxantrone and Ara-C with or without etoposide salvage chemotherapy in adult patients with relapsed or refractory acute lymphoblastic leukemia: retrospective multicenter study of the Korean Adult ALL Working Party.Jae-Sook Ahn et al.Acta haematologica, 133(1), 91-97 (2014-08-30)
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.Florence Joly et al.BJU international, 115(1), 65-73 (2013-11-05)
Release of an ~55kDa fragment containing the actin-binding domain of β-spectrin by caspase-8 during FND-induced apoptosis depends on the presence of protein 4.1.Monika Toporkiewicz et al.Archives of biochemistry and biophysics, 535(2), 205-213 (2013-04-13)
IMP3 protein promotes chemoresistance in breast cancer cells by regulating breast cancer resistance protein (ABCG2) expression.Sanjoy Samanta et al.The Journal of biological chemistry, 288(18), 12569-12573 (2013-03-30)
Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure.Korbelik M International Immunopharmacology, 20, 359-359 (2014)
Calreticulin as cancer treatment adjuvant: combination with photodynamic therapy and photodynamic therapy-generated vaccines.Korbelik M Frontiers in Oncology, 5, 15-15 (2015)
Cytosine arabinoside and mitoxantrone followed by second allogeneic transplant for the treatment of children with refractory juvenile myelomonocytic leukemia.Sachit A Patel et al.Journal of pediatric hematology/oncology, 36(6), 491-494 (2013-12-11)
Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.Denise P Muñoz et al.JCI insight, 5 (2019-06-12)
Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.Jae-Ho Yoon et al.American journal of hematology, 88(12), 1074-1081 (2013-08-29)
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.M Adamczyk-Sowa et al.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 63(6), 683-690 (2013-02-08)
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.Pau Abrisqueta et al.Blood, 122(24), 3951-3959 (2013-10-15)
Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.Enrico Derenzini et al.British journal of haematology, 166(4), 625-628 (2014-04-23)
Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.Pier Luigi Zinzani et al.American journal of hematology, 88(11), E273-E276 (2013-07-12)
A new target for an old drug: identifying mitoxantrone as a nanomolar inhibitor of PIM1 kinase via kinome-wide selectivity modeling.Xiaobo Wan et al.Journal of medicinal chemistry, 56(6), 2619-2629 (2013-02-28)
Mitoxantrone-related acute leukemia in MS: an open or closed book?Andrew Chan et al.Neurology, 80(16), 1529-1533 (2013-04-17)
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy.Susan Halabi et al.Journal of the National Cancer Institute, 105(22), 1729-1737 (2013-10-19)
MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).Meng-Tao Ma et al.Cancer letters, 339(1), 107-115 (2013-07-25)
In vitro analysis of the anti-cancer activity of mitoxantrone loaded on magnetic nanoparticles.Kwon-Jai Lee et al.Journal of biomedical nanotechnology, 9(6), 1071-1075 (2013-07-19)
Application of a novel microtitre plate-based assay for the discovery of new inhibitors of DNA gyrase and DNA topoisomerase VI.James A Taylor et al.PloS one, 8(2), e58010-e58010 (2013-03-08)
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia.Michaela Liedtke et al.Leukemia research, 38(12), 1441-1445 (2014-12-03)
Ultrasound-triggered disruption and self-healing of reversibly cross-linked hydrogels for drug delivery and enhanced chemotherapy.Nathaniel Huebsch et al.Proceedings of the National Academy of Sciences of the United States of America, 111(27), 9762-9767 (2014-06-26)
Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure.Mladen Korbelik et al.International immunopharmacology, 20(2), 359-365 (2014-04-10)
A template model for studying anticancer drug efflux transporter inhibitors in vitro.Alexandre Sostelly et al.Fundamental & clinical pharmacology, 27(5), 544-556 (2012-08-14)
Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.Fang-Fang Huang et al.Cancer letters, 336(1), 96-105 (2013-04-23)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!